Primary and secondary prevention of uterine cervical cancer: Up-To-Date Information, Guidelines, and the need for their application in Greece

Dimitra Mitsopoulou, Angeliki-Astero Papathanasiou, Emmanouil Kalampokas, Nikolaos Vlahos

Background/Aim: Human papilloma virus (HPV) and uterine cervical cancer (UCC) are causatively related. In Greece, evidence-based guidelines for primary and secondary prevention of UCC have yet to be developed and applied in clinical practice. Our purpose here is to present such guidelines together with up-to-date data on HPV screening protocols…

Complications and Management of Asymptomatic Patients with Measles Infection During Pregnancy

Zacharias N Fasoulakis, Georgios Galazios, Vasileios Liberis, Emmanuel N Kontomanolis

 

Measles virus is a member of the family Paramyxoviridae that causes an epidemic disease with worldwide distribution, with the main symptom of this systematic disease being a prodrome of fever and a pathognomonic enanthema (Koplik spots), followed by a maculopapular rash. The rash usually appears about 14 days after the patient’s exposure and even though vaccination has led the virus to be limited to preschool children and young adults, measles infection can cause severe and even fatal complications in adults, pregnant women and immunocomprised patients…

Prophylactic and therapeutic vaccines against HPV infection

Kontou S, Chaidogiannos K, Trianti M, Salamalekis E

Persistent infection with one of the oncogenic HPV types is necessary for the development of cervical cancer. The role of HPV in cervical carcinogenesis and their immune response have created expectations for prevention. Vaccines based on the induction of neutralizing antibodies against the HPV structural proteins L1 and L2 are termed “prophylactic”. Vaccines based on the induction …